[ad_1]
Edge Wealth Management LLC raised its holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 252.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 51,021 shares of the financial services provider’s stock after buying an additional 36,559 shares during the period. iShares Nasdaq Biotechnology ETF accounts for about 1.4% of Edge Wealth Management LLC’s portfolio, making the stock its 23rd largest holding. Edge Wealth Management LLC owned about 0.07% of iShares Nasdaq Biotechnology ETF worth $4,920,000 as of its most recent SEC filing.
A number of other hedge funds have also modified their holdings of IBB. Benjamin F. Edwards & Company Inc. boosted its holdings in shares of iShares Nasdaq Biotechnology ETF by 636.4% during the 3rd quarter. Benjamin F. Edwards & Company Inc. now owns 891 shares of the financial services provider’s stock worth $109,000 after buying an additional 770 shares during the period. Schroder Investment Management Group bought a new stake in iShares Nasdaq Biotechnology ETF in the 2nd quarter valued at about $105,000. North Star Investment Management Corp. boosted its holdings in iShares Nasdaq Biotechnology ETF by 21.6% in the 4th quarter. North Star Investment Management Corp. now owns 1,180 shares of the financial services provider’s stock valued at $114,000 after purchasing an additional 210 shares during the period. Cypress Capital Management LLC bought a new stake in iShares Nasdaq Biotechnology ETF in the 3rd quarter valued at about $201,000. Finally, Truvestments Capital LLC bought a new stake in iShares Nasdaq Biotechnology ETF in the 3rd quarter valued at about $203,000. Hedge funds and other institutional investors own 65.34% of the company’s stock.
NASDAQ IBB traded up $1.65 during trading on Friday, reaching $109.44. The company’s stock had a trading volume of 2,023,187 shares, compared to its average volume of 2,176,993. iShares Nasdaq Biotechnology ETF has a 12 month low of $89.01 and a 12 month high of $122.97.
ILLEGAL ACTIVITY WARNING: “Edge Wealth Management LLC Raises Holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)” was originally posted by Fairfield Current and is the sole property of of Fairfield Current. If you are accessing this article on another domain, it was copied illegally and republished in violation of international copyright & trademark laws. The correct version of this article can be read at https://www.fairfieldcurrent.com/news/2019/01/26/edge-wealth-management-llc-grows-holdings-in-ishares-nasdaq-biotechnology-etf-ibb.html.
iShares Nasdaq Biotechnology ETF Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Featured Article: Liquidity
Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com’s FREE daily email newsletter.
[ad_2]
Source link Google News
